# Use of CoG by Patients With Diabetes Mellitus

> **NCT03840161** · — · COMPLETED · sponsor: **Sciema UG** · enrollment: 40 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** non-invasive tissue glucose prediction

## Key facts

- **NCT ID:** NCT03840161
- **Lead sponsor:** Sciema UG
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-16
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-03-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03840161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03840161, "Use of CoG by Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT03840161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*